Page 36 - Differential Diagnosis in Small Animal Cytology, The Skin and Subcutis
P. 36

Cytological Criteria of Malignancy
                                                                                             23
             4.2  Nuclear Criteria
  VetBooks.ir  •	  Anisokaryosis and macrokaryosis/karyomegaly

                 Anisokaryosis (nuclear size variation) and macrokaryosis/karyomegaly (presence of excep-
                 tionally large nuclei) are considered significant when moderate to marked, although this
                 should be interpreted in the context of the characteristics of the tissue of origin.
             •	  Asynchronous nucleus to cytoplasm maturation
                 A marked variation of this ratio from the normal cell counterpart is considered an abnormal
                 finding.
             •	  Multinucleation
                 Multinucleation is particularly significant when nuclei within the same cell are variably sized and
                 in the presence of odd numbers of nuclei per cell. Certain non-neoplastic cell types are typically
                 multinucleated (e.g. megakaryocytes, osteoclasts, multinucleated giant  inflammatory cells).
             •	  Nucleoli
                 Nucleoli are nuclear substructures assigned to produce ribosomes and are considered a hall-
                 mark of malignancy when they become prominent, multiple, irregularly shaped (e.g. angular,
                 elongated, etc.) and variably sized (anisonucleosis). Some non-neoplastic cells normally
                 contain visible nucleoli (e.g. hepatocytes). Nucleoli may also be spuriously prominent in
                 cells that are either ruptured or  under-stained.
             •	  Coarse and/or variable chromatin pattern
                 The cytological evaluation of the chromatin should always be related to the pattern ob-
                 served in the non-neoplastic counterpart.



              (A)                                  (B)













              (C)                                  (D)














             Fig. 4.1.  Criteria of malignancy. (A) Anisokaryosis and nuclear moulding. (B) Multinucleation, nuclear fragmenta-
             tion and large prominent nucleoli. (C) Irregular nuclear shape. (D) Atypical mitosis.
   31   32   33   34   35   36   37   38   39   40   41